please find enclosed Annual Secretarial Compliance Report
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivo Bio Tech Ltd has submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2025, as required under Regulation 24A of SEBI's Listing Regulations. Practicing Company Secretary G. Vinay Babu reviewed the company's filings, website, and other relevant records, and confirmed that the company complied with all applicable SEBI regulations including LODR, Insider Trading, and Depositories rules. No observations or non-compliances were flagged across all 13 areas examined, covering secretarial standards, related party transactions, insider trading, and disclosures. There were also no actions taken by SEBI or stock exchanges against the company, and no instance of statutory auditor resignation during the review period.
This is a routine regulatory filing that confirms the company is in good regulatory standing with no compliance lapses or penalties during the year — neutral to mildly positive for shareholders as it indicates sound corporate governance.